Home › Renal Insufficiency › Florida › Hialeah
Renal Insufficiency clinical trials in Hialeah, FL
4 studies for Renal Insufficiency are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
RecruitingPhase 1Healthy volunteers welcome
- Floridian Clinical Research, LLC ( Site 0001), Miami Lakes · 4 mi away
A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
RecruitingPhase 1Healthy volunteers welcome
- Panax Clinical Research, LLC, Miami Lakes · 4 mi away
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- AGA Clinical Trials, Hialeah
- Convenient Medical Center, Hialeah
- Ocean Blue Medical Research Center - Internal Medicine, Miami Springs · 3 mi away
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
RecruitingPhase 1
- Floridian Clinical Research, Miami Lakes · 4 mi away
Renal Insufficiency trials in other cities
- Boston, MA7 studies
- Orlando, FL6 studies
- Houston, TX6 studies
- Durham, NC4 studies
- Dallas, TX4 studies
- Philadelphia, PA4 studies
- Phoenix, AZ3 studies
- Raleigh, NC3 studies
- Tampa, FL3 studies
- Seattle, WA3 studies
- New York City, NY3 studies
- Davie, FL3 studies
Other studies in Hialeah
- Obesity13 studies
- Schizophrenia13 studies
- Heart Failure12 studies
- Type 2 Diabetes10 studies
- Overweight10 studies
- Steatotic Liver Disease9 studies
- COPD8 studies
- Major Depressive Disorder8 studies
- Atherosclerosis8 studies
- Alzheimer's Disease6 studies
- Post-COVID Conditions (Long COVID)6 studies
- Cancer (all types)6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.